Painkiller
Micah Fitzerman-Blue and Noah Harpster
Netflix
IN DECEMBER 1995, the prescription drugs agency Purdue Pharma reached an essential milestone: its new opioid, OxyContin, was accepted by the US Meals and Drug Administration for the remedy of reasonable ache. One key side of the choice was a single sentence on the drug’s label claiming that its 12-hour delayed absorption was “believed” to scale back the chance of customers changing into hooked on it.
This semantic sidestep is one among many tales instructed in Painkiller …